Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
Boehringer Ingelheim is seeking a Principal Scientist to lead the in vitro antibody discovery team within the Biotherapeutics Discovery organization in Ridgefield, CT. The role includes developing and advancing discovery workflows that integrate automation, high-throughput screening, next-generation sequencing (NGS), and AI/ML-enabled approaches to enhance hit quality, accelerate timelines, and expand accessible sequence and functional diversity.
Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
Kernal Biologics